FindTrial
Sign In

Clinical investigation of biomarkers in exhaled breath with ion mobility spectrometry (IMS) and differential mobility spectrometry (DMS)

Clinical investigation of biomarkers in exhaled breath with ion mobility spectrometry (IMS) and differential mobility spectrometry (DMS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000314
Enrollment
90
Registered
2010-01-25
Start date
2010-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34.0 J44 E84.0 J84

Interventions

Group 1: Measurement of volatile organic compunds in exhaled breath

Sponsors

Kooperation der Abteilung für interventionelle Pneumologie (Chefarzt PD Lutz Freitag) und der Abteilung Pneumologie-Universitätsklinik (Chefarzt Prof. Helmut Teschler) des Westdeutsches Lungenzentrum am Universitätsklinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.) written Informed consent 2.) clinical, radiological or anamnestic findings in conformity with a malign lung tumor, cystic fibrosis, interstitial or infectious lung disease and patients listed for or after lung transplantation

Exclusion criteria

Exclusion criteria: not existent

Design outcomes

Primary

MeasureTime frame
discriminant analysis of volatile organic compunds in different lung diseases measured with ion mobility spectroscopy—

Countries

Germany

Contacts

Public ContactKaid Darwiche

Ruhrlandklinik - Uniklinikum Essen Westdeutsches Lungenzentrum Abt. für interventionelle Pneumologie

ruhrlandklinik@darwiche.de+49 201 433 4219

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026